Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. This ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Researchers made a “huge breakthrough” when they did an experiment “purely out of curiosity” which solves “a decades-long ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 15 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...

You’re an individual who is truly unique. We celebrate the passions that drive you and the possibilities that inspire you. Here, a degree is a pursuit of purpose where learning empowers you, ...